Koichiro Kanamori

Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with <i>EGFR</i> T790M mutation

Daisuke Hayakawa, Fumiyuki Takahashi, Yoichiro Mitsuishi et al. · Thoracic Cancer · 2019 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway

Hiroaki Ihara, Yoichiro Mitsuishi, Motoyasu Kato et al. · Respiratory Investigation · 2020 · 46 citations

Life Sciences, Cell Biology, Molecular Biology +12

Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma

T Kondo, Shigeyuki Ozawa, Takeharu Ikoma et al. · Oncogenesis · 2016 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

<scp>CALML5</scp> is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type <scp>B3</scp> thymoma

Koichiro Kanamori, Kentaro Suina, Takehito Shukuya et al. · Thoracic Cancer · 2023 · 11 citations · Full text

Medicine, Oncology, Pathology +17